首页> 外文OA文献 >OC-0481: Late toxicity and cosmesis after APBI with brachytherapy vs WBI: 5-year results of a phase III trial

【2h】

OC-0481: Late toxicity and cosmesis after APBI with brachytherapy vs WBI: 5-year results of a phase III trial

机译：OC-0481：APBI与近距离放射治疗相比APBI后的晚期毒性和美容效果：III期试验的5年结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Polgár C.; Strnad V.; Ott O.; Hildebrandt G.; Kauer-Dorner D.; Knauerhase H.; Major T.; Lyczek J.; Guinot J.; Dunst J.; Gutierrez Miguelez C.; Slampa P.; Allgäuer M.; Lössl K.; Polat B.; Kovács G.; Fischedick A.; Wendt T.; Hindemith M.; Resch A.; Niehoff P.; Guedea F.; Pötter R.; Gall C.; Uter W.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). [J] . Vicini F, Beitsch PD, Quiet CA, Cancer: A Journal of the American Cancer Society . 2008,第4期

机译：通过美国乳房外科医师协会MammoSite乳房近距离放射疗法注册管理系统试验对加速部分乳房照射（APBI）治疗的患者进行了为期三年的治疗效果，美容效果和毒性分析。
2. RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma-year-5 toxicity and cosmesis [J] . RabinovitchR., WinterK., KuskeR., Brachytherapy . 2014,第1期

机译：RTOG 95-17，II期试验，用于评估近距离放射疗法作为I和II期乳腺癌5年级毒性和美容的唯一放射疗法
3. Late side-eff ects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial [J] . Polgar Csaba, Ott Oliver J., Hildebrandt Guido, The lancet oncology . 2017,第2期

机译：晚期副作用和美容结果与间质近距离放射治疗随母乳术后的间隙近距离放射治疗，对母乳喂养的低风险侵袭性和原位癌的母乳喂养和原位癌：随机，控制的5年结果，第3阶段试验
4. Combining Dosimetry Toxicity: Analysis of two UK Phase III Clinical trials [C] . Sarah L Gulliford ICCR . 2014

机译：结合剂量测定和毒性：两个英国第三期临床试验分析
5. Examination of novel statistical designs for phase II and phase III clinical trials. [D] . Ayanlowo, Ayanbola Olajumoke. 2007

机译：检验II期和III期临床试验的新颖统计设计。
6. RTOG 95-17 A Phase II Trial to Evaluate Brachytherapy as the Sole Method of Radiation Therapy for Stage I and II Breast Carcinoma – Year-5 Toxicity and Cosmesis [O] . Rachel Rabinovitch, Kathryn Winter, Robert Kuske, -1

机译：RTOG 95-17II期试验用于评估近距离放射疗法作为I期和II期乳腺癌放射疗法的唯一方法–五年毒性和美容
7. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) [O] . Frank Vicini, Peter D. Beitsch, Coral A. Quiet, 2008

机译：美国乳房外科医生乳房外科医生乳房乳房近乳房辐射治疗注册表试验的治疗疗效，杂交和毒性为期三年分析，促进部分乳房辐照（APBI）

OC-0481: Late toxicity and cosmesis after APBI with brachytherapy vs WBI: 5-year results of a phase III trial

著录项

相似文献

相关主题

期刊订阅